Back to Search
JENNIFER MONTI, M.D.
M.D.
Cardiovascular Disease Physician
NPI: 1962729442IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
MD20969(ME)
Cardiovascular Disease PhysicianPrimary
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
82780(WI)MD20969(ME)
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
CMS Specialties
PrimaryCARDIOVASCULAR DISEASE (CARDIOLOGY)
Education
OTHER
Class of 2010
Research & Publications (20)
The roles of dopamine and serotonin, and of their receptors, in regulating sleep and waking.
PMID 18772053·Prog Brain Res·2008
6-review
The serotonin 5-HT7 receptor agonist LP-44 microinjected into the dorsal raphe nucleus suppresses REM sleep in the rat.
PMID 18466985·Behav Brain Res·2008
7-preclinical
Soluble epoxide hydrolase is a susceptibility factor for heart failure in a rat model of human disease.
PMID 18443590·Nat Genet·2008
7-preclinical
Activation of the serotonin 5-HT3 receptor in the dorsal raphe nucleus suppresses REM sleep in the rat.
PMID 18295951·Prog Neuropsychopharmacol Biol Psychiatry·2008
7-preclinical
The involvement of dopamine in the modulation of sleep and waking.
PMID 17275369·Sleep Med Rev·2007
6-review
Effects of the serotonin 5-HT2A/2C receptor agonist DOI and of the selective 5-HT2A or 5-HT2C receptor antagonists EMD 281014 and SB-243213, respectively, on sleep and waking in the rat.
PMID 17059817·Eur J Pharmacol·2006
7-preclinical
Effects of activation and blockade of 5-HT2A/2C receptors in the dorsal raphe nucleus on sleep and waking in the rat.
PMID 16713054·Prog Neuropsychopharmacol Biol Psychiatry·2006
4-observational
Effects of the 5-HT(7) receptor antagonist SB-269970 microinjected into the dorsal raphe nucleus on REM sleep in the rat.
PMID 16290281·Behav Brain Res·2006
4-observational
A study of the brain structures involved in the acute effects of fluoxetine on REM sleep in the rat.
PMID 15327697·Int J Neuropsychopharmacol·2005
4-observational
Effects of the 5-HT1A receptor ligands flesinoxan and WAY 100635 given systemically or microinjected into the laterodorsal tegmental nucleus on REM sleep in the rat.
PMID 15084431·Behav Brain Res·2004
4-observational
Effects of L-arginine and SIN-1 on sleep and waking in the rat during both phases of the light-dark cycle.
PMID 15312747·Life Sci·2004
4-observational
Sleep in schizophrenia patients and the effects of antipsychotic drugs.
PMID 15033152·Sleep Med Rev·2004
6-review
Microinjection of the nitric oxide synthase inhibitor L-NAME into the lateral basal forebrain alters the sleep/wake cycle of the rat.
PMID 14751418·Prog Neuropsychopharmacol Biol Psychiatry·2004
4-observational
Differential effects of the 5-HT1A receptor agonist flesinoxan given locally or systemically on REM sleep in the rat.
PMID 14575796·Eur J Pharmacol·2003
4-observational
The role of Wnk4 in polygenic hypertension: a candidate gene analysis on rat chromosome 10.
PMID 12642508·Hypertension·2003
7-preclinical
Interaction between blood pressure quantitative trait loci in rats in which trait variation at chromosome 1 is conditional upon a specific allele at chromosome 10.
PMID 12566390·Hum Mol Genet·2003
7-preclinical
Increased REM sleep after intra-dorsal raphe nucleus injection of flesinoxan or 8-OHDPAT: prevention with WAY 100635.
PMID 11788240·Eur Neuropsychopharmacol·2002
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 700 S PARK ST STE A
MADISON, WI 53715 - Phone
- (608) 260-2900
Quick Facts
- NPI
- 1962729442
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 4
- Locations
- 2
- Years in Practice
- 16
- Publications
- 20
Are you this provider?
Claim Your Profile